In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.

The most common cystic fibrosis transmembrane conductance regulator mutation, delta F508-CFTR, is a partially functional chloride channel that is retained in the endoplasmic reticulum and degraded. We hypothesize that a known transcriptional regulator, sodium 4-phenylbutyrate (4PBA), will enable a greater fraction of delta F508-CFTR to escape degradation and appear at the cell surface. Primary cultures of nasal polyp epithelia from CF patients (delta F508 homozygous or heterozygous), or the CF bronchial epithelial cell line IB3-1 (delta F508/W1282X) were exposed to 4PBA for up to 7 d in culture. 4PBA treatment at concentrations of 0.1 and 2 mM resulted in the restoration of forskolin-activated chloride secretion. Protein kinase A-activated, linear, 10 pS chloride channels appeared at the plasma membrane of IB3-1 cells at the tested concentration of 2.5 mM. Treatment of IB3-1 cells with 0.1-1 mM 4PBA and primary nasal epithelia with 5 mM 4PBA also resulted in the appearance of higher molecular mass forms of CFTR consistent with addition and modification of oligosaccharides in the Golgi apparatus, as detected by immunoblotting of whole cell lysates with anti-CFTR antisera. Immunocytochemistry in CF epithelial cells treated with 4PBA was consistent with increasing amounts of delta F508-CFTR. These data indicate that 4PBA is a promising pharmacologic agent for inducing correction of the CF phenotype in CF patients carrying the delta F508 mutation.

[1]  J. Dong,et al.  Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Bassett,et al.  Long-term treatment of girls with ornithine transcarbamylase deficiency. , 1996, The New England journal of medicine.

[3]  A S Verkman,et al.  Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. , 1996, Cell stress & chaperones.

[4]  H. Dietz,et al.  Both the wild type and a functional isoform of CFTR are expressed in kidney. , 1996, The American journal of physiology.

[5]  D. Bedwell,et al.  Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations , 1996, Nature Medicine.

[6]  P. Thomas,et al.  Alteration of the Cystic Fibrosis Transmembrane Conductance Regulator Folding Pathway , 1996, The Journal of Biological Chemistry.

[7]  J. Nelson,et al.  Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  J. Wine,et al.  Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation (*) , 1996, The Journal of Biological Chemistry.

[9]  Satoshi Omura,et al.  Degradation of CFTR by the ubiquitin-proteasome pathway , 1995, Cell.

[10]  J. Riordan,et al.  Multiple proteolytic systems, including the proteasome, contribute to CFTR processing , 1995, Cell.

[11]  J. Foskett,et al.  Mutant (δF508) Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channel Is Functional When Retained in Endoplasmic Reticulum of Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.

[12]  M. Welsh,et al.  Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression. , 1995, The American journal of physiology.

[13]  E. Schwiebert,et al.  Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells. , 1995, The American journal of physiology.

[14]  S. Brusilow,et al.  Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. , 1995, Blood.

[15]  J. Riordan,et al.  Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. , 1994, The Journal of biological chemistry.

[16]  J. Wilson,et al.  The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Johanna M. Rommens,et al.  The cystic fibrosis mutation (ΔF508) does not influence the chloride channel activity of CFTR , 1993, Nature Genetics.

[18]  S. McGrath,et al.  Cystic fibrosis gene and protein expression during fetal lung development. , 1993, American journal of respiratory cell and molecular biology.

[19]  P. Pedersen,et al.  Effects of the ΔF508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR , 1993, Journal of bioenergetics and biomembranes.

[20]  D. Faller,et al.  A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. , 1993, The New England journal of medicine.

[21]  J. Rommens,et al.  The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. , 1993, Nature genetics.

[22]  A. Hamosh,et al.  CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. , 1992, Human molecular genetics.

[23]  Matthew P. Anderson,et al.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive , 1992, Nature.

[24]  D. Samid,et al.  Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. , 1992, The New England journal of medicine.

[25]  T. Flotte,et al.  Defective regulation of outwardly rectifying Cl− channels by protein kinase A corrected by insertion of CFTR , 1992, Nature.

[26]  P. Pedersen,et al.  The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide. , 1992, The Journal of biological chemistry.

[27]  D. Benos,et al.  cAMP-stimulated ion currents in Xenopus oocytes expressing CFTR cRNA. , 1992, The American journal of physiology.

[28]  J. Riordan,et al.  Cl- channel activity in Xenopus oocytes expressing the cystic fibrosis gene. , 1991, The Journal of biological chemistry.

[29]  V. Ferrans,et al.  Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Chu,et al.  Down-regulation of cystic fibrosis gene mRNA transcript levels and induction of the cystic fibrosis chloride secretory phenotype in epithelial cells by phorbol ester. , 1991, The Journal of biological chemistry.

[31]  R. Craig,et al.  A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. , 1991, American journal of respiratory cell and molecular biology.

[32]  S. Brusilow.  Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion , 1991, Pediatric Research.

[33]  R. Crystal,et al.  Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. , 1991, Nature.

[34]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[35]  L. Kerschberg.  Letter from the editor , 2017, IEEE Data Eng. Bull..